News & Events
- Pfizer's Centers for Therapeutic Innovation (CTI) Seminar and One-on-One Meetings for NIH Intramural Researchers
- Translational Science 2015
- International Society for Extracellular Vesicles (ISEV) Annual Meeting
Pfizer's Centers for Therapeutic Innovation (CTI) Seminar and One-on-One Meetings for NIH Intramural Researchers
April 13, 2:00 – 5:00 p.m.; and April 14 by confirmed appointment
National Library of Medicine, Lister Hill Auditorium
8600 Rockville Pike, NIH Building 38A
Bethesda, Maryland 20894
NCATS will host a seminar as well as one-on-one meetings for NIH intramural researchers interested in Pfizer's Centers for Therapeutic Innovation (CTI) collaborative opportunities. The CTI model is the first NIH-wide biologics initiative with a pharmaceutical partner that NCATS will coordinate on behalf of all NIH intramural researchers; NIH investigators will be paired with Pfizer resources to pursue scientific and medical advances through joint therapeutic development. The goal of this new collaboration is to identify biologic compounds with activity in a pathway or target of interest to an NIH intramural researcher and to Pfizer. Together, the partners will work to move these compounds into the clinic to test them. The first Pfizer call for proposals from NIH intramural researchers is slated for spring 2015. Other partners in the CTI network include 25 academic institutions and four patient foundations. For more information and to register for April 13 and 14, contact Lili Portilla, NCATS director of strategic alliances, at NIH-PfizerCTI@mail.nih.gov.
April 16–18, 2015
Omni Shoreham Hotel
2500 Calvert Street NW
Washington, DC 20008
The Association for Clinical and Translational Science and American Federation for Medical Research are sponsoring the Translational Science 2015 Annual Meeting to bring together all of the disciplines involved in clinical and translational research, for the shared benefits of networking and education. The meeting will focus on engagement opportunities with leaders and peers and feature messages from plenary speakers. Educational sessions will provide information on the latest translational science information, as well as time to collaborate and share information through poster presentations, mock study sections, advocacy training and published research. Trainees and young investigators will have the opportunity to gain visibility at the meeting, as well as to meet one on one with NIH program directors.
Presenters include Petra Kaufmann, M.D., M.Sc., director of NCATS’ Division of Clinical Innovation and Robert M. Califf, M.D., principal investigator at the CTSA-supported Duke Translational Medicine Institute.
April 23–26, 2015
Bethesda North Marriott Hotel & Conference Center
5701 Marinelli Road
North Bethesda, Maryland 20852
The fourth annual meeting of ISEV will provide three and a half days of cutting-edge research presentations, plus keynote speakers including NIH Director Francis S. Collins, M.D., Ph.D., and Xandra O. Breakefield, Ph.D., extracellular vesicle pioneer and Harvard professor of neurology.
ISEV has scheduled a Joint Education Day as a prelude to this event (see below).
Joint Education Day
April 22, 2015, 9:00 a.m. to 5:30 p.m. ET
Hosted by the NIH Extracellular RNA Communication Consortium and ISEV, the fast-paced Joint Education Day will feature topics such as extracellular vesicle isolation, low-input RNA profiling, standards and spike-ins, and RNA-mediated communication.
May 27–28, 2015
Zuiderkerk, Amsterdam, NL
This conference will bring together key international stakeholders in translational research. Over two days, experts will present and discuss the main challenges in translational research, together with the new developments that EATRIS ERIC – the European Infrastructure for Translational Medicine, part of the European Research Infrastructure Consortium – contributes to the field. The conference will provide a unique opportunity to interact with a wide range of key stakeholders: patient organizations, research funders, and representatives from government industry and regulatory agencies.
On May 28, NCATS Director Christopher P. Austin, M.D., will serve as one of the keynote speakers during Session 4: Global Collaboration in Translational Medicine.
Please e-mail any questions to firstname.lastname@example.org.
June 17–18, 2015
8:30 a.m. to 5:00 p.m.
National Institutes of Health
Building 31C, 6th Floor, Conference Room 10
Bethesda, Md. 20892
This joint meeting of the NCATS Advisory Council and Cures Acceleration Network (CAN) Review Board will feature reports from NCATS Director Christopher P. Austin, M.D., and others about the Center’s initiatives, policies, programs and future direction. For more information about the Advisory Council and CAN Review Board, visit the NCATS Advisory Council page and the Cures Acceleration Network Review Board page of this site.